Monte Rosa Therapeutics, Inc. (GLUE)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch GLUE
See up to 3 months of GLUE. The 7-day demo opens the 1M and 3M ranges and puts GLUE on your watchlist.
Start 7-day demoLatest GLUE insider trades
- Matthew Bowen - OfficerOpen-market sale$137
Markus Warmuth
About Monte Rosa Therapeutics, Inc. (GLUE)
The SEC lists Monte Rosa Therapeutics, Inc. under CIK 0001826457, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
GLUE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 13,864 | $322K |
| Option exercise | 2 | 8,702 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GLUE insider transactions (Form 4)
6643 Form 4 filings on record, the earliest from Oct 30, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Matthew Bowen - Officer | Open-market sale | Common Stock | 13 | $10.56 | $137 | |
| Markus Warmuth - Officer | Open-market sale | Common Stock | 9,500 | $23.18 footnote F1 | $220K | |
| ||||||
 Jennifer Champoux - Officer | Option exercise | Common Stock | 4,351 | $3.98 | $17K | |
| Jennifer Champoux - Officer | Open-market sale | Common Stock | 4,351 | $23.38 footnote F2 | $102K | |
| Jennifer Champoux - Officer | Option exercise | Stock Option (Right to Buy) | 4,351 | $0.00 | - | |
| ||||||
 Sharon Townson - Officer | Option exercise | Common Stock | 6,000 | $6.14 | $37K | |
| Sharon Townson - Officer | Open-market sale | Common Stock | 5,600 | $23.25 footnote F2 | $130K | |
| Sharon Townson - Officer | Open-market sale | Common Stock | 400 | $24.13 | $10K | |
| Sharon Townson - Officer | Option exercise | Stock Option (Right to Buy) | 6,000 | $0.00 | - | |
| ||||||
 Ali Behbahani | Other | Common Stock | 1,000,000 | $0.00 | - | |
| Ali Behbahani | Other | Common Stock | 15,000 | $0.00 | - | |
| Ali Behbahani | Other | Common Stock | 15,000 | $0.00 | - | |
 Filip Janku - Officer | Option exercise | Common Stock | 5,407 | $13.41 | $73K | |
| Filip Janku - Officer | Open-market sale | Common Stock | 5,407 | $24.50 | $132K | |
| Filip Janku - Officer | Option exercise | Stock Option (Right to Buy) | 5,407 | $0.00 | - | |
| Filip Janku - Officer | Option exercise | Common Stock | 6,000 | $7.56 | $45K | |
| Filip Janku - Officer | Open-market sale | Common Stock | 6,000 | $22.95 | $138K | |
| Filip Janku - Officer | Option exercise | Stock Option (Right to Buy) | 6,000 | $0.00 | - | |
 Anthony M. Manning | Option exercise | Common Stock | 10,000 | $4.16 | $42K | |
| Anthony M. Manning | Open-market sale | Common Stock | 10,000 | $23.11 | $231K | |
| Anthony M. Manning | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Filip Janku - Officer | Open-market sale | Common Stock | 30,000 | $21.42 footnote F3 | $643K | |
| Filip Janku - Officer | Option exercise | Stock Option (Right to Buy) | 6,000 | $0.00 | - | |
| Filip Janku - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Filip Janku - Officer | Option exercise | Common Stock | 6,000 | $7.56 | $45K | |
| Filip Janku - Officer | Open-market sale | Common Stock | 11,845 | $20.22 footnote F2 | $240K | |
| Filip Janku - Officer | Option exercise | Common Stock | 30,000 | $7.56 | $227K | |
| ||||||
| Jennifer Champoux - Officer | Option exercise | Common Stock | 2,175 | $3.98 | $9K | |
| Jennifer Champoux - Officer | Open-market sale | Common Stock | 2,175 | $20.00 | $44K | |
| Jennifer Champoux - Officer | Option exercise | Stock Option (Right to Buy) | 2,175 | $0.00 | - | |
| Sharon Townson - Officer | Option exercise | Common Stock | 3,000 | $6.14 | $18K | |
| Sharon Townson - Officer | Open-market sale | Common Stock | 3,000 | $20.00 | $60K | |
| Sharon Townson - Officer | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| Jennifer Champoux - Officer | Option exercise | Stock Option (Right to Buy) | 2,176 | $0.00 | - | |
| Jennifer Champoux - Officer | Option exercise | Common Stock | 2,176 | $3.98 | $9K | |
| Jennifer Champoux - Officer | Open-market sale | Common Stock | 2,176 | $19.00 | $41K | |
| Sharon Townson - Officer | Option exercise | Common Stock | 3,000 | $6.14 | $18K | |
| Sharon Townson - Officer | Open-market sale | Common Stock | 3,000 | $19.00 | $57K | |
| Sharon Townson - Officer | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| Ali Behbahani | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Andrew N. Schiff | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Anthony M. Manning | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
 Jan Skvarka | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Kimberly Blackwell | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Eric A. Hughes | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Christine Siu | Grant or award | Stock Option (Right to Buy) | 25,800 | $0.00 | - | |
| Markus Warmuth - Officer | Open-market sale | Common Stock | 4,998 | $19.41 footnote F2 | $97K | |
| Markus Warmuth - Officer | Open-market sale | Common Stock | 468 | $19.73 footnote F3 | $9K | |
| ||||||
| Sharon Townson - Officer | Option exercise | Common Stock | 6,000 | $6.14 | $37K | |
| Sharon Townson - Officer | Open-market sale | Common Stock | 6,000 | $19.87 footnote F2 | $119K | |
| Sharon Townson - Officer | Option exercise | Stock Option (Right to Buy) | 6,000 | $0.00 | - | |
| ||||||
| Jennifer Champoux - Officer | Option exercise | Common Stock | 2,175 | $3.98 | $9K | |
| Jennifer Champoux - Officer | Open-market sale | Common Stock | 2,175 | $20.00 | $44K | |
| Jennifer Champoux - Officer | Option exercise | Stock Option (Right to Buy) | 2,175 | $0.00 | - | |
| Jennifer Champoux - Officer | Option exercise | Common Stock | 2,176 | $3.98 | $9K | |
| Jennifer Champoux - Officer | Open-market sale | Common Stock | 2,176 | $19.00 | $41K | |
| Jennifer Champoux - Officer | Option exercise | Stock Option (Right to Buy) | 2,176 | $0.00 | - | |
| Anthony M. Manning | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Anthony M. Manning | Option exercise | Common Stock | 10,000 | $4.16 | $42K | |
| Anthony M. Manning | Open-market sale | Common Stock | 10,000 | $18.01 | $180K | |
| Markus Warmuth - Officer | Open-market sale | Common Stock | 5,467 | $18.92 footnote F2 | $103K | |
| ||||||
| Markus Warmuth - Officer | Open-market sale | Common Stock | 8,000 | $17.64 footnote F1 | $141K | |
| ||||||
| Philip Nickson - Officer | Open-market sale | Common Stock | 5,845 | $17.69 footnote F1 | $103K | |
| ||||||
| Matthew Bowen - Officer | Grant or award | Common Stock | 4,300 | - footnote F1 | - | |
| Matthew Bowen - Officer | Grant or award | Stock Option (Right to Buy) | 19,500 | $0.00 | - | |
| ||||||
| Edmund Dunn - Officer | Open-market sale | Common Stock | 139 | $17.96 | $2K | |
Item 7.01, 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 2.02, 9.01
Item 5.07
Recent GLUE Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
GLUE insider trading FAQ
What is the latest insider trade for GLUE?
Monte Rosa Therapeutics, Inc. (GLUE) had 3 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for GLUE runs to 43 Form 4 filings, the earliest from 2024-10-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GLUE stock?
No insider purchases of GLUE were filed in the last 90 days.
How many insiders are selling GLUE stock?
3 insider sales of GLUE were filed in the last 90 days, totaling $322K.
Where can I see GLUE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GLUE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Matthew Bowen view on EDGAR
- - Markus Warmuth view on EDGAR
- - Jennifer Champoux view on EDGAR
- - Sharon Townson view on EDGAR
- - Ali Behbahani view on EDGAR
- - Filip Janku view on EDGAR
- - Filip Janku view on EDGAR
- - Anthony M. Manning view on EDGAR
- - Filip Janku view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GLUE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GLUE with a 7-day demo
- GLUE on your watchlist
- Every GLUE Form 4 filing on record
- Up to 3 months of GLUE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
